California AB2442 establishes a research and therapeutic access program for peptides and novel compounds.
California AB2442 creates a state-authorized research and therapeutic access program for peptides and novel compounds. The program aims to support scientific research and medically supervised investigational therapeutic access, complementing federal regulatory structures. The Department of Public Health will convene a working group to study potential uses, safety, and efficacy of these compounds. Participating entities, including the University of California and accredited medical schools, can establish research and access programs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.